Medical Marijuana. Navigating Medical Marijuana in Workers Compensation

Similar documents
Federal Law: Marijuana

Medical Cannabis MATT WEBSTER DO, MS

The Shifting Federal Regulation of Cannabis Products

Act 16 and Medical Cannabis in Pennsylvania

A look at Marijuana in 2014

The Sale of Cannabis in Pharmacies. Michael H. Ghobrial, PharmD, JD Associate Director, Health Policy American Pharmacists Association

Outcome. Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

9/28/2015. Support. R01CA A1 Intervening with smoking parents of inpatients to reduce

Curious about Cannabis? Navigating the cannabis landscape in Pennsylvania LINDSEY MESTON, PHARMD ASHLEY FIRM, PHARMD

Workplace Issues Associated with Legalized Marijuana. James B. Yates, Esq., SHRM-SCP, SPHR

POLICY NUMBER: POL 153

Medical Marijuana. Speaker Disclosure Requirements. Share with a Partner 4/10/2015

Medical Cannabis. Danial Schecter, MD, CCFP. Vocational Rehabilitation Association November 7th, Executive Director Cannabinoid Medical Clinic

Medical Marijuana Consent Form

Medical Marijuana: The Move to Schedule II

Medicinal cannabis. What is medicinal cannabis? What are cannabinoids? The endocannabinoid system

Use of Cannabinoids in Medical Practice

ADVANCED CLINICAL CANNABINOID PROVIDER EXAM ACCP

Medical Marijuana. Gina C. Guzman, MD, DBIM, FALU, FLMI. Munich Re US (Life) 17 Nov 2016

Medical Marijuana. 1. is a plant species, variety known as hemp. 3. Tetrahydrocannabinol is an aromatic with low water solubility.

Marijuana and Adolescents: Truth and Consequences. Disclosure Statement OBJECTIVES. Secondary Objectives. State of Marijuana in US

SECTION V: EMPLOYEES POLICY 5375 MEDICAL MARIJUANA, HEMP & CANNABIDIOL (CBD)

Maine s Medical Marijuana Law. 40 th Annual ASMAC Fall Conference Ritz Carlton Lake Tahoe October 26, 2014

Frequently Asked Questions

This questionnaire will ask you about approved medical use of extracts and tinctures of cannabis at national level.

Medical Marijuana (Cannabis) and Workplace Drug Testing and Safety. Joel Blanchard MD FACEP

Is the most common illicit drug used in the United States. After a period of decline in the last decade, its use has been increasing among young

MEDICAL MARIJUANA: WHAT S THE EVIDENCE?

MARIJUANA IN THE PUBLIC WORKPLACE PHILIP A. TOOMEY

History of Medical Cannabis in Nursing

8/31/2016. Workplace Implications of Marijuana in the US. Goal

AGENDA. 9:00 Sign-in and introductions 9:15 Marijuana 10:30 Break 10:45 Opioid Prevention 11:30 Discussion & Wrap-Up

Changing the Drug Enforcement Administration (DEA) Schedule of Tetrahydrocannabinol (THC), Cannabidiol and Combinations to Promote Research

Cannabis in the Workplace: Lessons Learned. Sponsored by:

CDHA 2016 Fall Symposium. Speaker Handout Files. For registered attendees only

Medical Marihuana for Patients in the Lymphoma Setting. Speakers: Ruth Turner, RN, Con Rob Laister, PhD

From heroin to medical marijuana: what districts need to know Megan Greulich, Staff Attorney Hot Topics in School Law October 5, 2016

Navigating the Rapidly Changing World of Marijuana and the Workplace. January 16, 2018

Coalition for Medical Marijuana Research & Education

Medical Marijuana: Friend or foe of workers compensation?

Research: Medical Cannabis

Medical vs Recreational Use of Cannabis. 11 th December 2017

James McCormack BSc (Pharm), PharmD Professor Faculty of Pharmaceutical Sciences University of British Columbia Vancouver, BC, Canada

Reefer Mania: The State of Medical Marijuana in Florida

Marijuana in the Workplace: The 411 on 420

Cannabis and What we Know. Bonnie Schnittker RN PHN Public Health Nurse October 20, 2017

Understanding Maine s Medical Marijuana Law

The Cannabis model in Canada and the USA. Dr Mark A Ware MD MRCP MSc McGill University Montreal, Quebec, Canada

CHAPTER Committee Substitute for Committee Substitute for Senate Bill No. 1030

ENROLLED 2014 Legislature CS for CS for SB 1030, 1st Engrossed

50 Shades of Developing Gray Matter: Adolescents and Marijuana

4/15/2019. US States with Marijuana Laws in Have ACOG and SMFM taken notice? THE EFFECTS OF MARIJUANA USE ON PREGNANCY AND LACTATION

AZ s Medical Marijuana Law Overview and Considerations. Ryan Hurley Partner, Chair of MMJ Dept. Rose Law Group pc

Puget Sound Educational Service District

Georgia Cannabidiol Study Frequently Asked Questions

An HR Perspective: Medical Marijuana and How it Affects Employers

WiFi. Network: Renaissance Conference Password: officeteamfield. Sponsored by:

Public Policy Agenda 2016

Dr. Hagit Marchaim, Regulatory Affairs & Drug Development Consulting - HMC

Medical Marijuana Update Chris Belletieri, DO

Medical Marijuana in the Workforce. What This Is...And What It Isn t

The Return of Medicinal Cannabis

CANADIAN CANNABIS CRAZE (AND CONUNDRUM) Dr. Melissa Snider-Adler Chief Medical Review Officer DriverCheck Inc. Addiction Medicine Physician

MINNESOTA S MEDICAL CANNABIS PROGRAM

LEGAL ASPECTS of MEDICAL MARIJUANA Florida Nurse Practitioner Network Annual Conference September 17, 2018

Questionnaire 1 of 5: Cannabis Plant and Cannabis Resin. Introduction

Marijuana and the Workplace : Changing Times

Recent trends in medical cannabis use in Canada

Medical Marijuana in Workers Compensation Thursday, Sept 17, 2:15 pm 3:30 pm

Life s brighter under the sun MEDICAL CANNABIS AND GROUP BENEFITS PLAN COVERAGE

Dear Colleague SUPPLEMENTARY INFORMATION ON CANNABIS BASED PRODUCTS FOR MEDICINAL USE

Drugs & Alcohol in the Workplace: A Legal Introduction

CANNABIS FOR THE RHEUMATOLOGIST

Marijuana. Module 4 ALLIED TRADES ASSISTANCE PROGRAM PREVENTATIVE EDUCATION: SUBSTANCE USE DISORDER

Medical Marijuana Martin P. Eason MD, JD Associate Chief of Staff for Education Mountain Home VA Medical Center. Disclosure.

Northern California Chapter, ACP Update In Medicine

Office of University Counsel and Secretary of the Board of Regents

The Marijuana Law Trend and Resulting Impact on Healthcare Providers

Medical Marijuana and the Workplace: Human Rights Considerations for ONA Members

Medical Cannabis Program. Dr. Maureen Small Co Medical Director Andrea Sundberg Program Coordinator

Global Legal Cannabis Market: Size, Trends & Forecasts ( ) September 2018

Substitute HB 523 Outline

MEDICAL CANNABIS IN MINNESOTA

Cannabis and Cannabinoids: Review of Existing and Potential Therapeutic Applications in Oncology

Cannabinoids: access and symptom management in cancer

Minnesota. Prescribing and Dispensing Profile. Research current through November 2015.

COMIRB Protocol Number: PI: Madeline Cole, MS-III Michael Chan, MS-III Dan Matlock, MD MPH. Dear Fellow Medical Student,

Running Head: LEGALIZATION OF MARIJUANA 1 LEGALIZATION OF RECREATIONAL MARIJUANA IN CALIFORNIA

WHO Expert Committee on Drug Dependence Pre-Review: Cannabis plant and resin. Expert Peer Review 2

Pennsylvania House of Representatives. Joint Health and Judiciary Committee Hearing. Medical Cannabis - Health Care Forum

Doc, will you sign my medical. Fellow in Hematology/Medical Oncology General Internal Medicine Grand Rounds

PATIENT INTAKE FORM. Name: Address: Town: State: Zip Code: MMJ Card #: Exp. Date: Drivers License #: Exp. Date: Home Phone: Cell:

Marijuana and the Chronic Non-Cancer Pain Patient

Medicinal Marijuana: The Canadian Journey

THE STATE OF THE STATES-A REPORT ON MEDICAL CANNABIS PROGRAMS MID YEAR MEETING AND SCIENTIFIC SEMINAR APRIL 13, 2018 NASHVILLE, TENNESSEE DEBBY MIRAN

INITIAL PATIENT INTAKE FORM

Smoke and Mirrors: Navigating Medical Marijuana in the Workplace

The products being taken by children with epilepsy are not the equivalent of the marijuana widely used for recreational purposes.

Does Legality equal Legitimacy? The challenges of fostering safe practice with state legalization of marijuana

Transcription:

Medical Marijuana Navigating Medical Marijuana in Workers Compensation

Agenda Federal and State Laws Public Health Adverse Effects & Concerns Clinical Use Implications for Employers Implications for Workers Compensation Conclusion 2

Federal Law: Marijuana Marijuana is a Schedule I drug under Federal Controlled Substances Act Makes possession, usage, purchase, sale, and/or cultivation of marijuana illegal at the federal level Physicians recommend but don t issue prescriptions or dispense. Other Schedule I drugs include: Lysergic acid diethylamide (LSD), Diacetylmorphone (Heroin), Gamma Hydroxybutyric Acid (GHB), MDMA (aka: Ecstasy ) Makes research difficult 3

State Regulatory Status vs. Federal Law: Schedule I Shifting Sands as of Jan 2018: Current administration: Memo on enforcement Each state is different with state laws on dispensaries, growing, possession: Blue = legalized medical Green = recreational & legal 29 States and DC have marijuana in some form 9 States and DC allow recreational use as well as medical use 17 states allow for low THC use but not broad medical use Other gray states may have specific medical uses 4

Marijuana Basics: What s marijuana? Dried leaves, flowers, stems and seeds from Cannabis satvia or Cannabis indica plants May be found in a variety of dosage forms Contains TCH (tetrahydrocannabinol) and other compounds like CBD (cannabinoids) THC is the compound that causes euphoria Cannabinoids and other compounds do not cause the same high, and have other qualities Goldfrank s Toxicologic Emergencies - Chapter 83: Cannabinoids; Hemp: http://norml.org/marijuana/industrial/item/introduction-5; DEA Scheduling: http://www.justice.gov/dea/pr/multimedialibrary/publications/drug_of_abuse.pdf#page=68 5

Strains of Marijuana 2 Main Strains for Medical Marijuana Cannabis Sativa Cannabis Indica Less Common Strain Cannabis Ruderalis 6

Recreational vs. Medical Marijuana User Intent (High vs. Relief of medical condition) % THC typically higher in Recreational (causes euphoria) THC content has risen over the years Other chemicals typically higher in medical (including CBD and others) 7

Increasing Potency of THC 8

Marijuana Use: SAMHSA Most commonly used illicit drug in the US 2.6 million people aged 12 or older in 2016 tried marijuana for the first time in the past year. Only about a third of people aged 12 or older perceived great risk of harm from weekly marijuana use. When asked, 44.7 percent of youth aged 12 to 17 reported that it would be fairly easy for them to obtain marijuana. Substance Abuse and Mental Health Services Administration Report 9/28/17 9

Marijuana & Public Health: FDA & CDC Perspective https://www.fda.gov/newsevents/publichealthfocus/ucm421168.htm 10

Health Effects: CDC According to the CDC: About 1 in 10 marijuana users will become addicted. For people who begin using younger than 18, that number rises to 1 in 6 Poisoning risk rises with THC content Marijuana directly affects the brain- specifically memory, learning, attention, decisionmaking and coordination Long term health risks may include heart attack, stroke, addiction, lung health (bronchitis and other chronic conditions), cancer risk is uncertain Regular teen marijuana use has been linked with psychosis and increased risk for several mental problems, including depression, anxiety, suicidal thoughts, and personality disturbances 11

Cannabis and Driving Contradictory studies, caution advised 12

DOT and marijuana use Marijuana use remains unacceptable for workers subject to DOT regulations Safety-sensitive work Those subject to drug testing under DOT Pilots, bus drivers, truck drivers, armed security personnel, locomotive engineers, etc. Drug testing must follow specific guidelines 13

Access to marijuana Medical Marijuana is not a prescription drug- Not FDA approved No NDC unless a state grants a state-specific one for PDMP like like CT- anomaly State Laws determine how a physician certifies a patient or grants a card State Laws determine the set up of dispensaries There are some FDA approved pharmaceuticals but those are not the same 14

Marijuana Medicinal Use Marijuana contains more than 500 compounds Approximately 107 are called the cannabinoids Delta-9-tetrahydrocannabinol (THC) is the main psychoactive cannabinoid in marijuana Cannabinoids are extremely lipid soluble Besides THC, there are varying proportions of other cannabinoids, cannabidiol (CBD), cannabinol (CBN), etc. Lethal doses in humans are not known 15

Marijuana Medical Use Marijuana has medicinal properties Anti-emetic properties that relieve side effects of anticancer chemotherapy Muscle-relaxing & anticonvulsant effects The capacity to reduce the elevated intraocular pressure of glaucoma These medical benefits come at the cost of the psychoactive effects that often impair normal activities Growing research for pain, including neuropathic pain Medical marijuana is not included in any Workers Compensation treatment guidelines, such as the Official Disability Guidelines (ODG) and the American College of Occupational & Environmental Medicine (ACOEM) Practice Guidelines There are no clear indications for which medical marijuana has greater efficacy for the above conditions Patient s who have tried and failed other therapies may benefit 16

Endocannabinoid system 17

NUMBER OF STATES States vary in terms of conditions covered under medical marijuana regulations 30 Top 20 Common Conditions 25 20 15 10 5 0 CONDITIONS 18

Dispensaries Each state has different laws for dispensaries Staffing & Training Location Testing 19

Pharmacists as Dispensers of Marijuana Some states require pharmacy involvement in different ways: Three states require dispensing to be done by a pharmacist in the dispensary (CT, NY, MN). Dose (dosage form, %THC/CBD) is determined by condition Training for pharmacists varies by state May have patient counseling requirements & restrictions on days supply PA requires a pharmacist or physician on-site for dispensary when facility open to patients AR requires a pharmacist consultant for each dispensary States may have specific training requirements for physicians to certify patients for specific conditions (i.e., NY) Review state regs for NP, naturopaths, PAs, MDs Different testing requirements by state 20

Pharmacists Attitude Some in Support Seek a more active role in clinical applications for cannabis-based medicines Believe pharmacist should be involved as the drug experts and need to seize the opportunity Pharmacists are already experienced at dispensing controlled substances to the public NEED FOR TRAINING ON DOSING AND DRUG INTERACTIONS Some Opposed Unresolved legal and regulatory issues Marijuana scheduling and threat of federal prosecution Potential to lose DEA license for dispensing marijuana Request more trials showing clinical safety and efficacy Desire federally approved dosage forms and reclassification to enable legal sales No standard guidelines for dosing currently exist 21

TX Dispensaries Texas is now one of 17 states to pass a law allowing for the use of "low THC, high CBD" products for medical reasons in limited situations 3 dispensaries in the state 20 physicians registered to prescribe CBD oils Texas Compassionate Use act for specific uses Childhood seizures not responsive to other treatments 22

Variety of Dosage Forms Vaporized Smoked Edibles Topical Oils (CBD) State Laws determine allowed forms for medical marijuana 23

Pharmaceutical Dosage forms Synthetic THC products: Cesamet (nabilone) - chemotherapy-induced nausea/vomiting Marinol (dronabinol) Chemotherapy-associated nausea and vomiting refractory to other antiemetics AIDS-related anorexia Syndros (dronabinol) Liquid Loss of appetite (anorexia) in people with who have lost weight. Nausea and vomiting caused by anti-cancer medicine (chemotherapy) in people whose nausea and vomiting have not improved with usual anti-nausea medicines. 24

Not yet approved in US Sativex (nabiximols): General Information Oromucosal spray; close to 1:1 ratio of THC/CBD Indicated for muscle spasms in muscular sclerosis patients who do not respond to other treatments Available in 25 countries; mostly in Europe Undergoing Phase III trials in the US (GW Pharmaceuticals) Epidolex (cannabidiol) Orphan drug for pediatric epilepsy Dravet & Lennox-Gastaut Syndromes Still an investigational drug; NDA filed with FDA 2017 98% CBD and no THC Liquid form like Charlotte s Web 25

Workers Comp and Medical Marijuana Important to review case law and legal advice Review Drug Testing and Drug Free workplace policies Case law in some states has upheld that payers must reimburse medical Recent NCCI study cited 5 states and cases: https://www.ncci.com/articles/pages/ii_marijuana-conversation-insurer.aspx Connecticut, Maine, Minnesota, New Jersey, and New Mexico Cases pending in other states Other states prohibit health insurers from paying; handful of states preclude employers or workers comp payers from paying Examples, Florida and North Dakota Other states have upheld discrimination if employee with medical marijuana prescription fired solely on basis of use (RI, ME) 26

Other Challenges for payers Financial institution limitations due to federal status Can t pay dispensary directly Contracts with wholesalers, third-party payers and other business entities may prohibit because of the federally illegal status Consultation with attorney familiar with specific state workers compensation law is recommended to review policies Testing Not standardized limit like alcohol Need attorney review pre-employment, random and post-accident 27

Diagnostic Testing Cannabis Cannabinoids can be detected in plasma or urine Not an agreed upon standard for intoxication Variables affecting the duration of detection of urinary metabolites include: Dose Duration of use (chronic users vs new or intermittent users) Acute versus chronic use Route of exposure Sensitivity of the method Urine volume, concentration, and ph Using GC/MS, metabolites may be detected in the urine up to 7 days following single marijuana cigarette Goldfrank s Toxicologic Emergencies - Chapter 83: Cannabinoids 28

Areas of Potential Abuse in Medical Marijuana Laws Doctors who prescribe the drug for conditions not covered by the law Prescribing without evaluation of patient Drug seekers: people who lie about their symptoms to acquire a prescription Fake chronic pain & migraines Legitimate patients selling their medical marijuana to non-patients for a profit 29

Things to consider Evaluate for specific patient; Medical marijuana is not a silver bullet Dosage is difficult to determine and requires physician engagement Should be evaluated carefully and patient risk for substance abuse should be considered Conflicting evidence on impact on opioid use Can find evidence drawn from population studies in states with legalization Recent evidence shows that use may increase use of prescription opioids Am J Psychiatry. 2018 Jan 1;175(1):47-53. doi: 10.1176/appi.ajp.2017.17040413. Epub 2017 Sep 26. 30

Questions? 31